Back

Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia.

14 March 2021 (12:00 - 13:00)
Organised by:
Congress Presentation Part of: Live Abstract session - Cardiovascular prevention starts in the acute phase! Secondary Prevention ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Piret Asser

University of Tartu, Tartu (Estonia)

3 More presentations in this session

Presentation thumbnail
Vital exhaustion and risk of myocardial infarction in male population aged 25- 64 years in Russia/Siberia. Epidemiological program WHO Monica-psychosocial
Doctor D. Panov (Novosibirsk, RU)
Abstract
Presentation thumbnail
Combined improvement of insulin resistance and hypertension using whole body digital twin technology in diabetic hypertensives- a real world study
Doctor P. Shamanna (Bangalore, India, IN)
Abstract
Presentation thumbnail
Identification of familial hypercholesterolemia in acute coronary syndrome patients: are we missing the mark?
Doctor P. Garcia Bras (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Live Abstract session - Cardiovascular prevention starts in the acute phase!

The Event

Event poster

ACVC 2021

14 March 2021 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Secondary prevention after one-year of a cardiovascular rehabilitation program: a single-centre analysis
thumbnail
Congress Presentation
Secondary prevention in young patients after acute ST segment elevation myocardial infarction: missing the goals and suffering the penalties
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources